Why is "global health equity" the final frontier for the esophageal cancer market?
The final piece of the modern ESCC puzzle is the move toward making these high-tech treatments accessible on a global scale. Esophageal squamous cell carcinoma is particularly prevalent in regions like the "Esophageal Cancer Belt" across Asia and parts of Africa, where access to expensive immunotherapies has historically been limited. Today, we are seeing a surge in "bio-similar"...
0 Comentários 0 Compartilhamentos 119 Visualizações 0 Anterior
Patrocinado